Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)
在 salford.ac.uk 的电子邮件经过验证
被引用次数:119449
Andrew Sloan, MD, FACS

Andrew Sloan, MD, FACS

Piedmont Health & Case Western Reserve University School of Medicine
在 Piedmont.org 的电子邮件经过验证
被引用次数:64662
Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh
在 upmc.edu 的电子邮件经过验证
被引用次数:63414
Luis F. Parada

Luis F. Parada

Director, Brain Tumor Center, Memorial Sloan Kettering Cancer Center
在 mskcc.org 的电子邮件经过验证
被引用次数:55901
Saverio Minucci

Saverio Minucci

European Institute of Oncology and University of Milan
在 ieo.it 的电子邮件经过验证
被引用次数:43811
Gennaro Ciliberto

Gennaro Ciliberto

Istituto Nazionale Tumori "Regina Elena" Roma
被引用次数:38485
Christopher Heeschen

Christopher Heeschen

Candiolo Cancer Institute - FPO - IRCCS
在 ircc.it 的电子邮件经过验证
被引用次数:37888
Gil Mor

Gil Mor

Yale University/Wayne State University
在 med.wayne.edu 的电子邮件经过验证
被引用次数:37530
James Till

James Till

Professor Emeritus, University of Toronto
在 uhnres.utoronto.ca 的电子邮件经过验证
被引用次数:34297
Sendurai A. Mani

Sendurai A. Mani

Associate Director for Translational Oncology, Legorreta Cancer Center at Brown University
在 brown.edu 的电子邮件经过验证
被引用次数:33172
1 - 10